European research networks to facilitate drug research in children.


Journal

British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323

Informations de publication

Date de publication:
10 2022
Historique:
revised: 31 07 2020
received: 30 04 2020
accepted: 16 08 2020
pubmed: 8 9 2020
medline: 14 9 2022
entrez: 7 9 2020
Statut: ppublish

Résumé

Paediatric drug development faces several barriers. These include fragmentation of stakeholders and inconsistent processes during the conduct of research. This review summarises recent efforts to overcome these barriers in Europe. Two exemplar initiatives are described. The European Paediatric Translational Research Infrastructure facilitates preclinical research and other work that underpins clinical trials. conect4children facilitates the design and implementation of clinical trials. Both these initiatives listen to the voices of children and their advocates. Coordination of research needs specific effort that supplements work on science, resources and the policy context.

Identifiants

pubmed: 32893382
doi: 10.1111/bcp.14545
pmc: PMC9546307
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4258-4266

Informations de copyright

© 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Références

Eur J Pediatr. 2015 Apr;174(4):481-91
pubmed: 25241827
Arch Dis Child. 2019 Apr;104(4):385-388
pubmed: 30902887
Acta Paediatr. 2020 Mar;109(3):607-612
pubmed: 31532836
Br J Clin Pharmacol. 2022 Oct;88(10):4258-4266
pubmed: 32893382
Arch Dis Child. 2019 Jun;104(6):601-604
pubmed: 31101643
Birth Defects Res B Dev Reprod Toxicol. 2011 Aug;92(4):254-60
pubmed: 21638754
Arch Dis Child. 2019 May;104(5):494-500
pubmed: 31000534
Rand Health Q. 2017 Jan 13;6(2):13
pubmed: 28845351
Bull World Health Organ. 2003;81(11):815-20
pubmed: 14758408
Arch Dis Child. 2019 Sep;104(9):900-905
pubmed: 31201156
Paediatr Drugs. 2017 Dec;19(6):505-513
pubmed: 28900869
Eur J Cancer. 2015 Jan;51(2):218-24
pubmed: 25434924
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S10-S25
pubmed: 30248190
Pediatr Res. 2016 Apr;79(4):662-9
pubmed: 26650344
Eur J Cancer. 2020 Sep;136:116-129
pubmed: 32688206
Paediatr Drugs. 2016 Aug;18(4):251-60
pubmed: 27142473

Auteurs

Mark A Turner (MA)

Institute of Lifecourse and Medical Sciences, University of Liverpool, Liverpool Health Partners, Liverpool, UK.

Katharine Cheng (K)

Child Health Innovation Leadership Department (CHILD), Johnson and Johnson, High Wycombe, UK.

Saskia de Wildt (S)

Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Heidrun Hildebrand (H)

Pediatric Development, Research & Development, Pharmaceuticals, Bayer AG, Berlin, Germany.

Sabah Attar (S)

Institute of Lifecourse and Medical Sciences, University of Liverpool, Liverpool Health Partners, Liverpool, UK.

Paolo Rossi (P)

Academic Department of Pediatrics (DPUO), Unit of Perinatal infection and congenital infectious diseases, Bambino Gesu Children's Hospital-University of Rome Tor Vergata, Rome, Italy.

Donato Bonifazi (D)

Consorzio per Valutazioni Biologiche e Farmacologiche, Bari, Italy.

Adriana Ceci (A)

Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy.

Joana Claverol (J)

Institut de Recerca Sant Joan de Deu, Sant Joan de Deu Research Foundation, Barcelona, Spain.

Begonya Nafria (B)

Institut de Recerca Sant Joan de Deu, Sant Joan de Deu Research Foundation, Barcelona, Spain.

Carlo Giaquinto (C)

Division of Pediatric Infectious Diseases, Department of Woman's and Child's Health, University of Padua, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH